首页 > 产品目录 > 免疫学 > 抗体 > Anti-EGFR (phospho Y1068) antibody

Anti-EGFR (phospho Y1068) antibody

产品编号 :
英文名称 :
中文名称 :
产品等级 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
50uL
- +
产品详情
  • 产品名称

    Anti-EGFR (phospho Y1068)抗体
    参阅全部 EGFR 一抗

  • 描述

    兔多克隆抗体to EGFR (phospho Y1068)

  • 宿主

    Rabbit

  • 经测试应用

    适用于: ICC/IFWBmore details

  • 种属反应性

    与反应: Human

  • 免疫原

    Synthetic peptide corresponding to Human EGFR (phospho W1068).

  • 阳性对照

    • WB: A-431 and A549 whole cell lysate treated with EGF (200 ng/mL for 10 minutes). ICC: A-431 cells treated with 200 ng/mL of EGF for 10 minutes.

  • 常规说明


    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

    If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

  • 形式

    Liquid

  • 存放说明

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

  • 存储溶液

    pH: 7.30
    Preservative: 0.05% Sodium azide
    Constituents: PBS, 50% Glycerol, 0.1% BSA

  • 浓度

    • 50 µl 浓度为 0.2 mg/ml

  • 纯度

    Immunogen affinity purified

  • 纯化说明

    The antibody has been negatively preadsorbed using (i) a non phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated epidermal growth factor receptor (EGFR), and (ii) a generic tyrosine phosphorylated peptide to remove antibody that is reactive with phosphotyrosine, irrespective of the sequence. The final product is generated by affinity chromatography using an EGFR-derived peptide that is phosphorylated at tyrosine 1068.

  • 克隆

    多克隆

  • 同种型

    IgG

The Abpromise guarantee

Abpromise™承诺保证使用ab5644于以下的经测试应用

“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。

应用Ab评论说明
ICC/IF

1/100.

WB(5)

1/1000. Detects a band of approximately 185 kDa.

  • 数据库链接

  • 别名

    • EGF R antibody

    • EGFR antibody

    • EGFR_HUMAN antibody

    • Epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) antibody

    • Epidermal growth factor receptor (erythroblastic leukemia viral (v erb b) oncogene homolog avian) antibody

    • Epidermal growth factor receptor antibody

    • erb-b2 receptor tyrosine kinase 1 antibody

    • ERBB antibody

    • ERBB1 antibody

    • Errp antibody

    • HER1 antibody

    • mENA antibody

    • NISBD2 antibody

    • Oncogen ERBB antibody

    • PIG61 antibody

    • Proto-oncogene c-ErbB-1 antibody

    • Receptor tyrosine protein kinase ErbB 1 antibody

    • Receptor tyrosine-protein kinase ErbB-1 antibody

    • SA7 antibody

    • Species antigen 7 antibody

    • Urogastrone antibody

    • v-erb-b Avian erythroblastic leukemia viral oncogen homolog antibody

    • wa2 antibody

    • Wa5 antibody

    • Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody

    • Cell growth inhibiting protein 40 antibody

    • Cell proliferation inducing protein 61 antibody

  • Immunocytochemistry/ Immunofluorescence - Anti-EGFR (phospho Y1068) antibody (ab5644)

    Immunocytochemistry/ Immunofluorescence - Anti-EGFR (phospho Y1068) antibody (ab5644)

    Immunofluorescence analysis of A431 (Human epidermoid carcinoma cell line) cells labeling EGFR with ab5644 at 1/100 dilution, followed by Goat anti-rabbit IgG (H+L) Superclonal, Alexa Fluor® 488 conjugate was used as the secondary antibody at 1/2000 dilution (Panel a). Nuclei (Panel b) were stained with SlowFade® Gold Antifade Mountant with DAPI. F-actin (Panel c) was stained with Rhodamine Phalloidin. Panel (d) represents the merged image showing membrane localization. Panel (e) represents cells treated with antagonist, Afatinib (1µM for 6hrs) followed by EGF (200 ng/ml for 10 minutes), showing no Phospho-EGFR staining. Panel (f) shows untreated cells with no signal. Panel (g) represents control cells with no primary antibody to assess background. 

    The cells (in 70% confluent log phase treated with 200ng/ml of EGF for 10 minutes) were fixed with 4% paraformaldehyde for 10 minutes; permeabilized with 0.1% Triton X-100 for 10 minutes and blocked with 1% BSA for hour at room temperature. The images were captured at 60X magnification.

  • Western blot - Anti-EGFR (phospho Y1068) antibody (ab5644)

    Western blot - Anti-EGFR (phospho Y1068) antibody (ab5644)

    All lanes : Anti-EGFR (phospho Y1068) antibody (ab5644) at 1/1000 dilution

    Lane 1 : A431 (Human epidermoid carcinoma cell line) whole cell lysate with skimmed milk
    Lane 2 : A431 whole cell lysate treated with EGF (200 ng/mL for 10 minutes) with skimmed milk
    Lane 3 : A431 whole cell lysate treated with Gefitinib followed by EGF (1uM for 16 hours, 200 ng/mL for 10 minutes) with skimmed milk
    Lane 4 : A431 whole cell lysate treated with Afatinib followed by EGF (0.5 uM for 6 hours, 200 ng/mL for 10 minutes) with skimmed milk
    Lane 5 : A549 (Human lung carcinoma cell line) whole cell lysate with skimmed milk
    Lane 6 : A549 whole cell lysate treated with EGF (200 ng/mL for 10 minutes) with skimmed milk
    Lane 7 : A549 whole cell lysate treated with Afatinib followed by EGF (0.5 uM for 6 hours, 200 ng/mL for 10 minutes) with skimmed milk

    Lysates/proteins at 30 µg per lane.

    Blocking peptides at 5 % per lane.

    Secondary
    All lanes : Goat anti-Rabbit IgG Superclonal Secondary Antibody, HRP at 1/4000 dilution


    Western blot analysis using ab5644 shows increased expression of proteins phosphorylated at the tyrosine residues in A-431 and A549 cell lines upon EGF treatment and pre-treatment with EGFR-antagonists, Gefitinib and Afatinib. This results in inhibition of Phospho-EGFR in A-431 and A549 cell lines

  • Western blot - Anti-EGFR (phospho Y1068) antibody (ab5644)

    Western blot - Anti-EGFR (phospho Y1068) antibody (ab5644)This image is courtesy of an Abreview submitted by Mr Samir Nuseibeh

    All lanes : Anti-EGFR (phospho Y1068) antibody (ab5644) at 1/200 dilution

    Lane 1 : A431 (Human epidermoid carcinoma cell line) whole cell lysate - not treated
    Lane 2 : A431 whole cell lysate - 100ng/ml EGF for 1 minute
    Lane 3 : A431 whole cell lysate - 100ng/ml EGF for 2.5 minutes
    Lane 4 : A431 whole cell lysate - 100ng/ml EGF for 5 minutes
    Lane 5 : A431 whole cell lysate - 100ng/ml EGF for 10 minutes
    Lane 6 : A431 whole cell lysate - 100ng/ml EGF for 20 minutes
    Lane 7 : A431 whole cell lysate - 100ng/ml EGF for 40 minutes

    Secondary
    All lanes : HRP conjugated Goat anti-rabbit antibody

    Developed using the ECL technique.

    Performed under reducing conditions.

    Exposure time: 2 minutes

    See Abreview